| Next 10 |
Ad
AMGN News and Press Amgen Inc.
News | Amgen Inc. (NASDAQ:AMGN)
-
2024-12-12 14:23:18 ET It's been a banner year for the stock market. However, not every stock has been a winner as some sectors performed better than others. Tech and utilities soared, while others like real estate and healthcare underperformed. So what are the five worst performers on ...
-
2024-12-10 17:01:32 ET More on AbbVie, Amgen, etc. Regeneron: Recent Bear Run May Be Justified - Pharma Faces A Testing 2025 Johnson & Johnson Is A Better Dividend Stock Than Amgen In Our View Regeneron Pharmaceuticals, Inc. (REGN) Piper Sandler 36th Annual Healt...
-
2024-12-10 16:44:45 ET More on Amgen Johnson & Johnson Is A Better Dividend Stock Than Amgen In Our View Amgen Inc. (AMGN) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript) Amgen's Phase 2 Results Were Not Bad, Don't Let Mr. Market Fool You ...
-
AMGEN ANNOUNCES 2025 FIRST QUARTER DIVIDEND PR Newswire THOUSAND OAKS, Calif. , Dec. 10, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.38 per share dividend for the first quarter of 2025. The dividend will ...
-
2024-12-10 09:38:59 ET Biotech companies are making monumental strides in cancer treatment, leveraging cutting-edge technologies to redefine the field. Given the robust prospect, investors looking for fundamentally sound biotech stocks might consider adding Regeneron Pharmaceuticals (REGN...
-
2024-12-09 04:36:00 ET Whether you're looking for a way to beat the benchmark S&P 500 index or you just want a steady flow of passive income, dividend-paying stocks are a great way to achieve your investment goals. Once companies commit to sharing a portion of their profits with...
-
2024-12-07 10:39:00 ET It's time to take a look at the " Dogs of the Dow ." Are the highest-yielding stocks of the Dow Jones Industrial Average (DJINDICES: ^DJI) index undervalued, fantastic buys -- or did their prices fall and dividend yields soar for scary reasons? Stock ...
-
BLINCYTO® (BLINATUMOMAB) ADDED TO CHEMOTHERAPY SIGNIFICANTLY IMPROVES SURVIVAL IN NEWLY DIAGNOSED PEDIATRIC PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) PR Newswire Phase 3 Study Results Demonstrated Three Year, Disease-Free Survival of 96% ...
-
2024-12-06 18:28:05 ET Summary Regeneron Pharmaceuticals, Inc.'s stock has dropped 30% since July due to concerns around Eylea's declining market share in the face of competition from generics and Roche's Vabysmo. Dupixent's growth, with potential revenues of ~$20bn by 2030, offer...
-
2024-12-06 13:50:52 ET Summary Recent market concerns have pressured the stock prices of both Johnson & Johnson and Amgen Inc. In times of uncertainties, I go back to timeless insights like those offered by Peter Lync on dividend stocks. These insights led me to rate JNJ a...
Stock Information
Get AMGN Alerts
News, Short Squeeze, Breakout and More Instantly...
Ad
-
2024-12-12 14:23:18 ET It's been a banner year for the stock market. However, not every stock has been a winner as some sectors performed better than others. Tech and utilities soared, while others like real estate and healthcare underperformed. So what are the five worst performers on ...
-
AMGEN ANNOUNCES 2025 FIRST QUARTER DIVIDEND PR Newswire THOUSAND OAKS, Calif. , Dec. 10, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.38 per share dividend for the first quarter of 2025. The dividend will ...
-
2024-12-10 09:38:59 ET Biotech companies are making monumental strides in cancer treatment, leveraging cutting-edge technologies to redefine the field. Given the robust prospect, investors looking for fundamentally sound biotech stocks might consider adding Regeneron Pharmaceuticals (REGN...